CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
CVRx, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.35+0.05 (+3.85%)
Close on Oct 19, 2026
- Market cap
- $35.80M
- P/E (TTM)
- –
- Dividend yield
- –
CVRx, Inc. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | TTM Q2 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $54.33M | $51.88M | $51.30M | $50.10M | $48.53M | $47.17M | $43.10M | $40.38M | $38.00M | $35.11M | $30.80M | $26.26M | 92.0% | +11.9% |
| Germany | – | – | – | – | – | $4.13M | $3.36M | $3.35M | $3.68M | $3.69M | $3.55M | $3.68M | – | – |
| Other countries | – | – | – | $2.77M | $2.56M | $665.00K | $2.48M | $2.34M | $1.28M | $494.00K | $810.00K | $894.00K | – | – |
From the segment and revenue-disaggregation notes of CVRx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.